Annual BioHealth Capital Region Forum Showcases Robust Growth Across 4th Largest Biopharma Cluster

Published on :

The Sixth Annual BioHealth Capital Region Forum brought together industry leaders from across the region who discussed the accomplishments and strengths of the region as its member companies continue to innovate new therapies and medicines in one of the strongest bio-hub regions in the United States.

2020 BioHealth Capital Region Virtual Forum & Crab Trap Competition

Published on :

This invitation-only event is free for executive level biotech leaders and is presented by the Association of University Research Parks, AstraZeneca, BioHealth Innovation, Children’s National Health System, Emergent BioSolutions, George Mason University, J.P. Morgan, Johns Hopkins University, Maryland Department of Commerce, Virginia Bio, and Wilson Sonsini Goodrich & Rosati, P.C.

These Seed and Early-Stage Investment Funds in Maryland Are Fueling Life Science Startups

Published on :

Perhaps the single biggest challenge faced by startup entrepreneurs and early-stage life science companies is securing the necessary funding to fuel innovation and growth. The BioHealth Capital Region (BHCR) life science community as a whole faces a similar challenge when it comes to access to venture capital funding; this challenge has been noted by many BHCR thought leaders and well-documented in a host of BioBuzz stories.

5 Questions with Judy Costello, Managing Director of Economic Development for BioHealth Innovation, Inc. (BHI)

Published on :

Judy Costello is Managing Director of Economic Development for BioHealth Innovation, Inc. (BHI). Prior to joining BHI, she served as Director of the Maryland Department of Commerce’s Office of BioHealth and Life Sciences and as Deputy Director of the department’s BioMaryland Center.

BioHealth Capital Fund Created to Help Emerging Companies Close Early Stage Capital Gap

Published on :

BioHealth Innovation (BHI) was created in 2012 by Rich Bendis and key industry leaders to accelerate the commercialization of high potential scientist entrepreneurs and companies within the BioHealth Capital Region (BHCR), which consists of Maryland, Virginia and Washington, D.C.

National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Announces Virtual Pediatric Pitch Competition Winners

National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Announces Virtual Pediatric Pitch Competition Winners
Published on :

National Capital Consortium for Pediatric Device Innovation (NCC-PDI) Announces Virtual Pediatric Pitch Competition Winners The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) recently announced the winners of its annual [….]

4 Key Insights for Startups and Entrepreneurs Looking to Grow a Life Science Business

Published on :

4 Key Insights for Startups and Entrepreneurs Looking to Grow a Life Science Business BioHealth Capital Region Key Opinion Leaders and Connectors Share Thoughts on Growing the Region’s Innovation Ecosystem [….]

Raising Capital During a Pandemic: Strong Networks and Respected Advocates Remain Critical to Fundraising Efforts

Raising Capital During a Pandemic
Published on :

Raising Capital During a Pandemic: Strong Networks and Respected Advocates Remain Critical to Fundraising Efforts Talk to any experienced venture capital investor and they’ll tell you that personal, face-to-face interactions [….]

Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO

William Hearl - CEO, Chairman of the Board, and Founder of Immunic Therapeutics
Published on :

Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO Immunomic Therapeutics Incorporated (ITI), located in Rockville, Maryland recently announced it had closed on $61.3M in financing, exceeding its initial fundraising [….]